CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dimerix Ltd Company Snapshot
Dimerix Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dimerix Ltd with three other miscellaneous service companies in Australasia: Race Oncology Ltd (2021 sales of 18,847.00 Australian Dollars [US$13,677.08 ] ), Argenica Therapeutics Ltd (202.00 Australian Dollars [US$146.59 ] of which 100% was Research and development of medical devi), and Antisense Therapeutics Limited (4,181.00 Australian Dollars [US$3,034.11 ] ).

Sales Analysis. Dimerix Ltd reported sales of A$1,506.00 (US$1.09 thousand) for the fiscal year ending June of 2021. This represents a sharp decrease of 44.2% versus 2020, when the company's sales were A$2,700.00 .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dimerix Ltd
  Stock Performance Chart for Dimerix Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): .31
(Figures in Australian Dollars)
1 Week 10.7%   13 Weeks -3.1%  
4 Weeks 44.2%   52 Weeks 26.5%  
 
Dimerix Ltd Key Data:
  Ticker: DXB Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 1,506
(Year Ending Jan 2022).
Employees: 9
  Currency: Australian Dollars Market Cap: 61,379,782
  Fiscal Yr Ends: June Shares Outstanding: 197,999,297
  Share Type: Ordinary Closely Held Shares: 67,078,532
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.